Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System
Tóm tắt
Từ khóa
Tài liệu tham khảo
Yelin, 2020, Long-term consequences of COVID-19: research needs, Lancet Infect Dis, 20, 1115, 10.1016/S1473-3099(20)30701-5
Zheng, 2020, Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis, J Infect, 81, e16, 10.1016/j.jinf.2020.04.021
Gold, 2020, COVID-19 and comorbidities: a systematic review and meta-analysis, Postgrad Med, 132, 1, 10.1080/00325481.2020.1786964
Mantovani, 2020, Diabetes as a risk factor for greater COVID-19 severity and in-hospital death: a meta-analysis of observational studies, Nutr Metab Cardiovasc Dis, 30, 1236, 10.1016/j.numecd.2020.05.014
Yang, 2020, Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis, Int J Infect Dis., 94, 91, 10.1016/j.ijid.2020.03.017
Yang, 2020, Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study, Lancet Respir Med, 8, 475, 10.1016/S2213-2600(20)30079-5
Zuin, 2020, Arterial hypertension and risk of death in patients with COVID-19 infection: systematic review and meta-analysis, J Infect, 81, e84, 10.1016/j.jinf.2020.03.059
Lee, 2020, Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study, Lancet Psychiatry, 7, P1025, 10.1016/S2215-0366(20)30421-1
Dyett, 2020, Possible link between obesity and severe COVID-19, Med J Aust, 213, 380, 10.5694/mja2.50793
Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3
Zhu, 2020, Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing Type 2 diabetes, Cell Metab, 31, 1068, 10.1016/j.cmet.2020.04.021
Wu, 2020, Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, 180, 934, 10.1001/jamainternmed.2020.0994
Chen, 2020, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ, 368, m1091, 10.1136/bmj.m1091
Tu, 2020, Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan, Intensive Care Med, 46, 1117, 10.1007/s00134-020-06023-4
Chen, 2020, Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China: a single-centered, retrospective study, J Gerontol A Biol Sci Med Sci, 75, 1788, 10.1093/gerona/glaa089
Yao, 2020, A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients, Pol Arch Intern Med, 130, 390, 10.20452/pamw.15312
Zhang, 2020, The clinical data from 19 critically ill patients with coronavirus disease 2019: a single-centered, retrospective, observational study, Z Gesundh Wiss, 10.21203/rs.3.rs-20800/v1
Wang, 2020, 15-day mortality and associated risk factors for hospitalized patients with COVID-19 in Wuhan, China: an ambispective observational cohort study, Intensive Care Med, 46, 1472, 10.1007/s00134-020-06047-w
Li, 2020, Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) Infection in Wuhan, China, JAMA Cardiol, 5, 825, 10.1001/jamacardio.2020.1624
Inciardi, 2020, Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy, Eur Heart J, 41, 1821, 10.1093/eurheartj/ehaa388
Du, 2020, Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study, Eur Respir J, 55, 2000524, 10.1183/13993003.00524-2020
Guan, 2020, Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis, Eur Respir J, 55, 2001227, 10.1183/13993003.01227-2020
2020, The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China, Zhonghua Liu Xing Bing Xue Za Zhi, 41, 145, 10.3760/cma.j.issn.0254-6450.2020.02.003
Guan, 2020, Clinical characteristics of Coronavirus Disease 2019 in China, N Engl J Med, 382, 1708, 10.1056/NEJMoa2002032
Deng, 2020, Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study, Chin Med J, 133, 1261, 10.1097/CM9.0000000000000824
Wang, 2020, Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up, J Infect, 80, 639, 10.1016/j.jinf.2020.03.019
de Almeida-Pititto, 2020, Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis, Diabetol Metab Syndr, 12, 75, 10.1186/s13098-020-00586-4
Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x
Wang, 2020, Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19, Am J Respir Crit Care Med, 201, 1430, 10.1164/rccm.202003-0736LE
Liu, 2020, Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19, J Infect, 81, e6, 10.1016/j.jinf.2020.04.002
Cao, 2020, Clinical features and short-term outcomes of 102 patients with Coronavirus Disease 2019 in Wuhan, China, Clin Infect Dis, 71, 748, 10.1093/cid/ciaa243
Kumar, 2020, Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis, Diabetes Metab Syndr, 14, 535, 10.1016/j.dsx.2020.04.044
Akbari, 2020, Early epidemiological analysis of COVID-19: first report from South of Iran, Res Square, 10.21203/rs.3.rs-19915/v1
Bai, 2020, Clinical and laboratory factors predicting the prognosis of patients with COVID-19: an analysis of 127 patients in Wuhan, China, Lancet Respir Med, 10.2139/ssrn.3546118
Lu, 2020, Clinical characteristics and risk factors for fatal outcome in patients with 2019-Coronavirus Infected Disease (COVID-19) in Wuhan, Lancet, 10.2139/ssrn.3546069
Fu, 2020, Influence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort study, medRxiv, 10.1101/2020.03.13.20035329
Li, 2020, Predictors of fatality including radiographic findings in adults with COVID-19, Respir Res., 21, 146, 10.1186/s12931-020-01411-2
Luo, 2020, Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China, medRxiv, 10.1101/2020.03.19.20033175
Yuan, 2020, Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China, PLoS ONE, 15, e0230548, 10.1371/journal.pone.0230548
Huang, 2020, Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression, Diabetes Metab Syndr, 14, 395, 10.1016/j.dsx.2020.04.018
Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585
Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5
Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, 395, 507, 10.1016/S0140-6736(20)30211-7
Chen, 2020, Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia, Zhonghua Jie He He Hu Xi Za Zhi, 43, E005, 10.3760/cma.j.issn.1001-0939.2020.0005
Fu, 2020, Analysis on the clinical characteristics of 36 cases of novel coronavirus pneumonia in Kunming, medRxiv, 10.1101/2020.02.28.20029173
Guo, 2020, Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19), JAMA Cardiol, 5, 811, 10.1001/jamacardio.2020.1017
Liu, 2020, Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province, Chin Med J, 133, 1025, 10.1097/CM9.0000000000000744
Liu, 2020, The epidemiological and clinical characteristics of 2019 novel coronalvirus infection in Changsha, China, Lancet Infect Dis, 10.2139/ssrn.3537093
Peng, 2020, Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV, Zhonghua Xin Xue Guan Bing Za Zhi, 48, 450, 10.3760/cma.j.cn112148-20200220-00105
Shi, 2020, Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study, Lancet Infect Dis, 20, 425, 10.1016/S1473-3099(20)30086-4
Shi, 2020, Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China, JAMA Cardiol, 5, 802, 10.1001/jamacardio.2020.0950
Tang, 2020, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, 18, 844, 10.1111/jth.14768
Wang, 2020, Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China, Clin Infect Dis, 71, 769, 10.1093/cid/ciaa272
Xu, 2020, Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series, BMJ, 368, m606, 10.1136/bmj.m606
Miller, 2020, Diabetes mellitus increases the risk of hospital mortality in patients with Covid-19: systematic review with meta-analysis, Medicine, 99, e22439, 10.1097/MD.0000000000022439
Du, 2020, Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study, Am J Respir Crit Care Med, 201, 1372, 10.1164/rccm.202003-0543OC
Li, 2020, Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China, Int J Infect Dis, 94, 128, 10.1016/j.ijid.2020.03.053
Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area, JAMA, 323, 2052, 10.1001/jama.2020.6775
Hussain, 2020, Burden of diabetes mellitus and its impact on COVID-19 patients: a meta-analysis of real-world evidence, Diabetes Metab Syndr, 14, 1595, 10.1016/j.dsx.2020.08.014
Gu, 2020, History of coronary heart disease increases the mortality rate of COVID-19 patients: a nested case-control study, BMJ Open., 10, e038976, 10.1136/bmjopen-2020-038976
2020, Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study, Lancet, 396, 27, 10.1016/S0140-6736(20)31182-X
Chen, 2020, Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication, Diabetes Care, 43, 1399, 10.2337/dc20-0660
Zhang, 2020, Myocardial injury is associated with in-hospital mortality of confirmed or suspected COVID-19 in Wuhan, China: a single center retrospective cohort study, medRxiv, 10.1101/2020.03.21.20040121
Ssentongo, 2020, Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: a systematic review and meta-analysis, PLoS ONE, 15, e0238215, 10.1371/journal.pone.0238215
Holman, 2020, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol, 8, 823, 10.1016/S2213-8587(20)30271-0
Barron, 2020, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, Lancet Diabetes Endocrinol, 8, 813, 10.1016/S2213-8587(20)30272-2
Beagley, 2014, Global estimates of undiagnosed diabetes in adults, Diabetes Res Clin Pract, 103, 150, 10.1016/j.diabres.2013.11.001
Unsworth, 2020, New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K., Diabetes Care, 43, e170, 10.2337/dc20-1551
Pung, 2020, Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures, Lancet, 395, 1039, 10.1016/S0140-6736(20)30528-6
Lauer, 2020, The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann Intern Med, 172, 577, 10.7326/M20-0504
Li, 2020, Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, 382, 1199, 10.1056/NEJMoa2001316
Song, 2020, Immunological and inflammatory profiles in mild and severe cases of COVID-19, Nat Commun, 11, 3410, 10.1038/s41467-020-17240-2
Chen, 2020, Clinical and immunological features of severe and moderate coronavirus disease 2019, J Clin Invest, 130, 2620, 10.1172/JCI137244
Keeley, 2020, Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary, BMJ Support Palliat Care, 10, 381, 10.1136/bmjspcare-2020-002368
Zhou, 2020, Imaging features and evolution on CT in 100 COVID-19 pneumonia patients in Wuhan, China, Eur Radiol, 30, 5446, 10.1007/s00330-020-06879-6
Connors, 2020, COVID-19 and its implications for thrombosis and anticoagulation, Blood, 135, 2033, 10.1182/blood.2020006000
Tavakolpour, 2020, Lymphopenia during the COVID-19 infection: what it shows and what can be learned, Immunol Lett, 225, 31, 10.1016/j.imlet.2020.06.013
Wang, 2020, Temporal changes of CT findings in 90 patients with COVID-19 Pneumonia: a Longitudinal Study, Radiology, 296, E55, 10.1148/radiol.2020200843
Radermecker, 2020, Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19, J Exp Med, 217, e20201012, 10.1084/jem.20201012
Carsana, 2020, Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study, Lancet Infect Dis, 20, 1135, 10.1016/S1473-3099(20)30434-5
Liu, 2020, Viral dynamics in mild and severe cases of COVID-19, Lancet Infect Dis, 20, 656, 10.1016/S1473-3099(20)30232-2
Sungnak, 2020, SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes, Nat Med, 26, 681, 10.1038/s41591-020-0868-6
Al-Sarraj, 2020, The spectrum of neuropathology in COVID-19, Neuropathol Appl Neurobiol, 10.1111/nan.12667
Vasquez-Bonilla, 2020, A review of the main histopathological findings in coronavirus disease 2019, Hum Pathol, 105, 74, 10.1016/j.humpath.2020.07.023
Wu, 2020, Substantial underestimation of SARS-CoV-2 infection in the United States, Nat Commun, 11, 4507, 10.1038/s41467-020-18272-4
Sette, 2020, Pre-existing immunity to SARS-CoV-2: the knowns and unknowns, Nat Rev Immunol, 20, 457, 10.1038/s41577-020-0389-z
Le, 2020, SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls, Nature, 584, 457, 10.1038/s41586-020-2550-z
Lee, 2020, Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a Community Treatment Center in the Republic of Korea, JAMA Intern Med, 180, 1447, 10.1001/jamainternmed.2020.3862
Eckerle, 2020, SARS-CoV-2 seroprevalence in COVID-19 hotspots, Lancet, 396, 514, 10.1016/S0140-6736(20)31482-3
Alanagreh, 2020, The Human Coronavirus Disease COVID-19: its origin, characteristics, and insights into potential drugs and its mechanisms, Pathogens, 9, 331, 10.3390/pathogens9050331
Fehr, 2015, Coronaviruses: an overview of their replication and pathogenesis, Methods Mol Biol, 1282, 1, 10.1007/978-1-4939-2438-7
Yao, 2020, Molecular Architecture of the SARS-CoV-2 Virus, Cell, 183, 730, 10.1101/2020.07.08.192104
Skowronski, 2005, Severe acute respiratory syndrome (SARS): a year in review, Annu Rev Med, 56, 357, 10.1146/annurev.med.56.091103.134135
Khailany, 2020, Genomic characterization of a novel SARS-CoV-2, Gene Rep, 19, 100682, 10.1016/j.genrep.2020.100682
Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5
Sehnal, 2018, Mol*: Towards a common library and tools for web molecular graphics, MolVA/EuroVis Proceedings
Kuba, 2010, Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters, Pharmacol Ther, 128, 119, 10.1016/j.pharmthera.2010.06.003
Zhang, 2007, Collectrin, a homologue of ACE2, its transcriptional control and functional perspectives, Biochem Biophys Res Commun, 363, 1, 10.1016/j.bbrc.2007.08.136
Zhou, 2020, A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature, 579, 270, 10.1038/s41586-020-2012-7
Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052
Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058
Xia, 2020, Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein, Cell Mol Immunol, 17, 765, 10.1038/s41423-020-0374-2
Liu, 2004, Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors, Lancet, 363, 938, 10.1016/S0140-6736(04)15788-7
Xu, 2004, Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus, Biochemistry, 43, 14064, 10.1021/bi049101q
Gui, 2017, Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding, Cell Res, 27, 119, 10.1038/cr.2016.152
Yuan, 2017, Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains, Nat Commun, 8, 15092, 10.1038/ncomms15092
Shang, 2020, Cell entry mechanisms of SARS-CoV-2, Proc Natl Acad Sci USA, 117, 11727, 10.1073/pnas.2003138117
McKinney, 2014, Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling, Clin Sci, 126, 815, 10.1042/CS20130436
Carey, 2003, Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation, Endocr Rev, 24, 261, 10.1210/er.2003-0001
Hayashi, 2010, The counterregulating role of ACE2 and ACE2-mediated angiotensin 1–7 signaling against angiotensin II stimulation in vascular cells, Hypertens Res, 33, 1182, 10.1038/hr.2010.147
Benigni, 2010, Angiotensin II revisited: new roles in inflammation, immunology and aging, EMBO Mol Med, 2, 247, 10.1002/emmm.201000080
Garvin, 2020, A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm, Elife, 9, e59177, 10.7554/eLife.59177
Turner, 2004, ACE2: from vasopeptidase to SARS virus receptor, Trends Pharmacol Sci, 25, 291, 10.1016/j.tips.2004.04.001
Hamming, 2004, Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis, J Pathol, 203, 631, 10.1002/path.1570
Zou, 2020, Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection, Front Med, 14, 185, 10.1007/s11684-020-0754-0
Guy, 2005, Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis, FEBS J, 272, 3512, 10.1111/j.1742-4658.2005.04756.x
Lambert, 2005, Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2), J Biol Chem, 280, 30113, 10.1074/jbc.M505111200
Heurich, 2014, TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein, J Virol, 88, 1293, 10.1128/JVI.02202-13
Epelman, 2008, Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system, J Am Coll Cardiol, 52, 750, 10.1016/j.jacc.2008.02.088
Patel, 2014, Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS, J Mol Cell Cardiol, 66, 167, 10.1016/j.yjmcc.2013.11.017
Tipnis, 2000, A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase, J Biol Chem, 275, 33238, 10.1074/jbc.M002615200
Zoufaly, 2020, Human recombinant soluble ACE2 in severe COVID-19, Lancet Respir Med, 8, 1154, 10.1016/S2213-2600(20)30418-5
Batlle, 2020, Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?, Clin Sci, 134, 543, 10.1042/CS20200163
Blanco-Melo, 2020, Imbalanced host response to SARS-CoV-2 drives development of COVID-19, Cell, 181, 1036, 10.1016/j.cell.2020.04.026
Brubaker, 2015, Innate immune pattern recognition: a cell biological perspective, Annu Rev Immunol, 33, 257, 10.1146/annurev-immunol-032414-112240
Heil, 2004, Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8, Science, 303, 1526, 10.1126/science.1093620
Zhang, 2018, Structural analyses of toll-like receptor 7 reveal detailed RNA sequence specificity and recognition mechanism of agonistic ligands, Cell Rep, 25, 3371, 10.1016/j.celrep.2018.11.081
Tanji, 2015, Toll-like receptor 8 senses degradation products of single-stranded RNA, Nat Struct Mol Biol, 22, 109, 10.1038/nsmb.2943
Honda, 2006, Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors, Immunity, 25, 349, 10.1016/j.immuni.2006.08.009
Tenoever, 2007, Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity, Science, 315, 1274, 10.1126/science.1136567
Ran, 2014, MITA/STING: a central and multifaceted mediator in innate immune response, Cytokine Growth Factor Rev, 25, 631, 10.1016/j.cytogfr.2014.05.003
Barber, 2011, Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses, Curr Opin Immunol, 23, 10, 10.1016/j.coi.2010.12.015
Maringer, 2014, Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection, Cytokine Growth Factor Rev, 25, 669, 10.1016/j.cytogfr.2014.08.004
Wu, 2019, Inflammasome activation triggers blood clotting and host death through pyroptosis, Immunity, 50, 1401, 10.1016/j.immuni.2019.04.003
Yap, 2020, Inflammasomes and pyroptosis as therapeutic targets for COVID-19, J Immunol, 205, 307, 10.4049/jimmunol.2000513
Berthelot, 2020, Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?, Emerg Microbes Infect, 9, 1514, 10.1080/22221751.2020.1785336
Zhang, 2020, STING is an essential regulator of heart inflammation and fibrosis in mice with pathological cardiac hypertrophy via endoplasmic reticulum (ER) stress, Biomedicine & Pharmacotherapy, 125, 110022, 10.1016/j.biopha.2020.110022
Borden, 2007, Interferons at age 50: past, current and future impact on biomedicine, Nat Rev Drug Discovery, 6, 975, 10.1038/nrd2422
Grifoni, 2020, Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals, Cell, 181, 1489, 10.1016/j.cell.2020.05.015
Sekine, 2020, Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19, Cell, 183, 158, 10.1101/2020.06.29.174888
Wang, 2020, Neutralizing antibodies responses to SARS-CoV-2 in COVID-19 inpatients and convalescent patients, Clin Infect Dis, 10.1101/2020.04.15.20065623
Ng, 2020, Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans, Science., 370, 1339, 10.1126/science.abe1107
Wu, 2020, Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications, medRxiv, 10.2139/ssrn.3566211
Muecksch, 2020, Longitudinal analysis of serology and neutralizing antibody levels in COVID19 convalescents, jiaa659, 10.1093/infdis/jiaa659
Chen, 2020, T cell responses in patients with COVID-19, Nat Rev Immunol, 20, 529, 10.1038/s41577-020-0402-6
Long, 2020, Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections, Nat Med, 26, 1200, 10.1038/s41591-020-0965-6
Lee, 2020, Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19, Sci Immunol, 5, abd1554, 10.1126/sciimmunol.abd1554
Acharya, 2020, Dysregulation of type I interferon responses in COVID-19, Nat Rev Immunol, 20, 397, 10.1038/s41577-020-0346-x
Hadjadj, 2020, Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients, Science, 369, 718, 10.1126/science.abc6027
Wang, 2020, Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts, J Leukoc Biol, 108, 17, 10.1002/JLB.3COVR0520-272R
Yang, 2020, Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19, J Allergy Clin Immunol, 146, 119, 10.1016/j.jaci.2020.04.027
Mann, 2020, Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19, Sci Immunol, 5, abd6197, 10.1126/sciimmunol.abd6197
Qin, 2020, Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China, Clin Infect Dis, 71, 762, 10.1093/cid/ciaa248
Bryce, 2020, Pathophysiology of SARS-CoV-2: targeting of endothelial cells renders a complex disease with thrombotic microangiopathy and aberrant immune response. The Mount Sinai COVID-19 autopsy experience, medRxiv, 10.1101/2020.05.18.20099960
Zhang, 2020, COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes, J Leukoc Biol, 109, 13, 10.1002/JLB.4HI0720-470R
Muir, 2016, Innate lymphoid cells are the predominant source of il-17a during the early pathogenesis of acute respiratory distress syndrome, Am J Respir Crit Care Med, 193, 407, 10.1164/rccm.201410-1782OC
Tang, 2020, Cytokine Storm in COVID-19: the current evidence and treatment strategies, Front Immunol, 11, 1708, 10.3389/fimmu.2020.01708
Ragab, 2020, The COVID-19 cytokine storm; what we know so far, Front Immunol, 11, 1446, 10.3389/fimmu.2020.01446
Gao, 2020, Cytokine storm syndrome in coronavirus disease 2019: a narrative review, J Intern Med, 10.1111/joim.13144
Leisman, 2020, Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes, Lancet Respir Med, 8, 1233, 10.1016/S2213-2600(20)30404-5
Mazzoni, 2020, Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent, J Clin Invest, 130, 4694, 10.1172/JCI138554
Diao, 2020, Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19), Front Immunol, 11, 827, 10.3389/fimmu.2020.00827
Zheng, 2020, Functional exhaustion of antiviral lymphocytes in COVID-19 patients, Cell Mol Immunol, 17, 533, 10.1038/s41423-020-0402-2
2020, Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison, Lancet Infect Dis, 20, 1390, 10.1016/S1473-3099(20)30634-4
Whitman, 2020, Evaluation of SARS-CoV-2 serology assays reveals a range of test performance, Nat Biotechnol, 38, 1174, 10.1038/s41587-020-0659-0
Faustini, 2020, Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection, medRxiv, 10.1101/2020.06.16.20133025
Yu, 2020, Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients, Eur Respir J, 56, 2020, 10.1183/13993003.01526-2020
Ma, 2020, Serum IgA, IgM, and IgG responses in COVID-19, Cell Mol Immunol, 17, 773, 10.1038/s41423-020-0474-z
Hasan, 2020, Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies, Clin Infect Dis., ciaa1496, 10.1093/cid/ciaa1496
Varadhachary, 2020, Salivary anti-SARS-CoV-2 IgA as an :accessible biomarker of mucosal immunity against COVID-19, medRxiv, 10.1101/2020.08.07.20170258
Zhang, 2020, Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19, Front Mol Biosci, 7, 157, 10.3389/fmolb.2020.00157
Alexandraki, 2008, Cytokine secretion in long-standing diabetes mellitus type 1 and 2: associations with low-grade systemic inflammation, J Clin Immunol, 28, 314, 10.1007/s10875-007-9164-1
Davidson, 1984, Defective phagocytosis in insulin controlled diabetics: evidence for a reaction between glucose and opsonising proteins, J Clin Pathol, 37, 783, 10.1136/jcp.37.7.783
Delamaire, 1997, Impaired leucocyte functions in diabetic patients, Diabet Med, 14, 29, 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
Huang, 2019, Distinct neutrophil counts and functions in newly diagnosed type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes, Diabetes Metab Res Rev, 35, e3064, 10.1002/dmrr.3064
Lecube, 2011, Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement, PLoS ONE, 6, e23366, 10.1371/journal.pone.0023366
Marhoffer, 1992, Impairment of polymorphonuclear leukocyte function and metabolic control of diabetes, Diabetes Care, 15, 256, 10.2337/diacare.15.2.256
Hull, 2017, Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?, Diabetologia, 60, 1839, 10.1007/s00125-017-4377-1
Blandino-Rosano, 2008, Anti-proliferative effect of pro-inflammatory cytokines in cultured beta cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide−1, J Mol Endocrinol, 41, 35, 10.1677/JME-07-0154
Okubo, 2016, Treg activation defect in type 1 diabetes: correction with TNFR2 agonism, Clin Transl Immunol, 5, e56, 10.1038/cti.2015.43
Ip, 2016, Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFalpha production, Obesity, 24, 102, 10.1002/oby.21243
Nicholas, 2019, Fatty acid metabolites combine with reduced beta oxidation to activate Th17 inflammation in human type 2 diabetes, Cell Metab, 30, 447, 10.1016/j.cmet.2019.07.004
Carey, 2018, Risk of infection in Type 1 and Type 2 diabetes compared with the general population: a matched cohort study, Diabetes Care, 41, 513, 10.2337/dc17-2131
Critchley, 2018, Glycemic control and risk of infections among people with type 1 or Type 2 diabetes in a large primary care Cohort Study, Diabetes Care, 41, 2127, 10.2337/dc18-0287
Wang, 2020, Fasting blood glucose at admission is an independent predictor for 28-day mortality in patients with COVID-19 without previous diagnosis of diabetes: a multi-centre retrospective study, Diabetologia, 63, 2102, 10.1007/s00125-020-05209-1
Liu, 2020, Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury, Sci China Life Sci, 63, 364, 10.1007/s11427-020-1643-8
Henry, 2020, Circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): a preliminary report, Prog Cardiovasc Dis, 63, 702, 10.1016/j.pcad.2020.07.006
Jarcho, 2020, Inhibitors of the renin-angiotensin-aldosterone system and Covid-19, N Engl J Med, 382, 2462, 10.1056/NEJMe2012924
Tralhao, 2020, Potential benefit of angiotensin II in COVID-19 patients: beyond reasonable doubt?, Crit Care, 24, 324, 10.1186/s13054-020-03027-w
Flacco, 2020, Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis, Heart, 106, 1519, 10.1136/heartjnl-2020-317336
Vaduganathan, 2020, Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19, N Engl J Med, 382, 1653, 10.1056/NEJMsr2005760
Aronson, 2020, Drugs and the renin-angiotensin system in covid-19, BMJ, 369, m1313, 10.1136/bmj.m1313
Hippisley-Cox, 2020, Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people, Heart, 106, 1503, 10.1136/heartjnl-2020-317393
Braude, 2020, The influence of ACE inhibitors and ARBs on hospital length of stay and survival in people with COVID-19, IJC Heart Vasculature, 31, 100660, 10.1016/j.ijcha.2020.100660
Mehra, 2020, Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19, New England J Med, 382, e102, 10.1056/NEJMoa2007621
Koka, 2008, Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway, Am J Pathol, 172, 1174, 10.2353/ajpath.2008.070762
Soler, 2007, ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice, Kidney Int, 72, 614, 10.1038/sj.ki.5002373
Chen, 2020, Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation, Aging Cell, 19, e13168, 10.1111/acel.13168
Anderson, 1993, Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations, Am J Physiol, 265, F477, 10.1152/ajprenal.1993.265.4.F477
Tikellis, 2003, Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy, Hypertension, 41, 392, 10.1161/01.HYP.0000060689.38912.CB
Rao, 2020, Exploring Diseases/traits and blood proteins causally related to expression of ACE2, the Putative Receptor of SARS-CoV-2: a mendelian randomization analysis highlights tentative relevance of diabetes-related traits, Diabetes Care, 43, 1416, 10.2337/dc20-0643
Roca-Ho, 2017, Characterization of ACE and ACE2 expression within different organs of the NOD mouse, Int J Mol Sci, 18, 563, 10.3390/ijms18030563
Fang, 2020, Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?, Lancet Respir Med, 8, e21, 10.1016/S2213-2600(20)30116-8
Muller, 2005, Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus, Clin Infect Dis, 41, 281, 10.1086/431587
Kulcsar, 2019, Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection, JCI Insight, 4, e131774, 10.1172/jci.insight.131774
Hulme, 2017, Influenza virus and glycemic variability in diabetes: a killer combination?, Front Microbiol, 8, 861, 10.3389/fmicb.2017.00861
Carroll, 2010, Adaptive immunity to rhinoviruses: sex and age matter, Respir Res, 11, 184, 10.1186/1465-9921-11-184
Giefing-Kroll, 2015, How sex and age affect immune responses, susceptibility to infections, and response to vaccination, Aging Cell, 14, 309, 10.1111/acel.12326
Klein, 2012, Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases, Bioessays, 34, 1050, 10.1002/bies.201200099
Oh, 2019, Aging and the Immune System: the Impact of Immunosenescence on viral infection, immunity and vaccine immunogenicity, Immune Netw, 19, e37, 10.4110/in.2019.19.e37
Kautzky-Willer, 2016, Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus, Endocr Rev, 37, 278, 10.1210/er.2015-1137
Apicella, 2020, COVID-19 in people with diabetes: understanding the reasons for worse outcomes, Lancet Diabetes Endocrinol, 8, 782, 10.1016/S2213-8587(20)30238-2
Deng, 2016, Altered peripheral B-lymphocyte subsets in type 1 diabetes and latent autoimmune diabetes in adults, Diabetes Care, 39, 434, 10.2337/dc15-1765
Mira, 2017, Persistent inflammation, immunosuppression and catabolism syndrome, Crit Care Clin, 33, 245, 10.1016/j.ccc.2016.12.001
Hawkins, 2018, Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome, Front Immunol, 9, 1511, 10.3389/fimmu.2018.01511
Salminen, 2021, Increased immunosuppression impairs tissue homeostasis with aging and age-related diseases, J Mol Med, 99, 1, 10.1007/s00109-020-01988-7
Rydyznski, 2020, Antigen-specific adaptive immunity to SARS-CoV-2 in Acute COVID-19 and associations with age and disease severity, Cell, 183, 996, 10.1016/j.cell.2020.09.038
Daoust, 2020, Elderly people and responses to COVID-19 in 27 Countries, PLoS ONE, 15, e0235590, 10.1371/journal.pone.0235590
Cicco, 2020, Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment, Mediators Inflamm, 2020, 7527953, 10.1155/2020/7527953
Land, 2020, Role of damage-associated molecular patterns in light of modern environmental research: a tautological approach, Int J Environ Res, 14, 583, 10.1007/s41742-020-00276-z
AlGhatrif, 2020, The Dilemma of Coronavirus Disease 2019, Aging, and Cardiovascular Disease: Insights From Cardiovascular Aging Science, JAMA Cardiol, 5, 747, 10.1001/jamacardio.2020.1329
Tomar, 2020, Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19, Cells, 9, 1383, 10.3390/cells9061383
Webb, 2020, Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study, Lancet Rheumatol, 2, e754, 10.1016/S2665-9913(20)30343-X
Williamson, 2020, OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients, Nature., 584, 430, 10.1038/s41586-020-2521-4
Thierry, 2020, Neutrophil extracellular traps and by-products play a key role in COVID-19: pathogenesis, risk factors, and therapy, J Clin Med, 9, 2942, 10.3390/jcm9092942
Kalyanaraman, 2020, Do free radical NETwork and oxidative stress disparities in African Americans enhance their vulnerability to SARS-CoV-2 infection and COVID-19 severity?, Redox Biol, 37, 101721, 10.1016/j.redox.2020.101721
Wang, 2020, Neutrophil-to-lymphocyte ratio at admission is an independent risk factors for the severity and mortality in patients with coronavirus disease 2019, J Infect, 10.1016/j.jinf.2020.09.022
Veras, 2020, SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology, J Exp Med, 217, e20201129, 10.1084/jem.20201129
de Vries, 2020, Effects of diabetes mellitus on fibrin clot structure and mechanics in a model of acute Neutrophil Extracellular Traps (NETs) Formation, Int J Mol Sci, 21, 7107, 10.3390/ijms21197107
Jin, 2020, Neutrophil extracellular traps (NETs)-mediated killing of carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) are impaired in patients with diabetes mellitus, Virulence, 11, 1122, 10.1080/21505594.2020.1809325
Birra, 2020, COVID 19: a clue from innate immunity, Immunol Res, 68, 161, 10.1007/s12026-020-09137-5
Bandyopadhyay, 2020, COVID-19 pandemic: cardiovascular complications and future implications, Am J Cardiovasc Drugs, 20, 311, 10.1007/s40256-020-00420-2
Clerkin, 2020, COVID-19 and cardiovascular disease, Circulation, 141, 1648, 10.1161/CIRCULATIONAHA.120.046941
Seirafianpour, 2020, Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review, Dermatol Ther, 33, e13986, 10.1111/dth.13986
Ackermann, 2020, Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19, N Engl J Med, 383, 120, 10.1056/NEJMoa2015432
Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5
Le Brocq, 2008, Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities, Antioxid Redox Signal, 10, 1631, 10.1089/ars.2007.2013
Shaw, 2014, Endothelial cell oxidative stress in diabetes: a key driver of cardiovascular complications?, Biochem Soc Trans, 42, 928, 10.1042/BST20140113
Gu, 2012, Association of intercellular adhesion molecule 1 (ICAM1) with diabetes and diabetic nephropathy, Front Endocrinol, 3, 179, 10.3389/fendo.2012.00179
Ribau, 1999, Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients, J Surg Res, 85, 225, 10.1006/jsre.1999.5682
McLeod, 1995, Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid, Am J Pathol, 147, 642
Lim, 2004, Soluble CD40 ligand, soluble P-selectin, interleukin-6, and tissue factor in diabetes mellitus: relationships to cardiovascular disease and risk factor intervention, Circulation, 109, 2524, 10.1161/01.CIR.0000129773.70647.94
Sandoo, 2010, The endothelium and its role in regulating vascular tone, Open Cardiovasc Med J, 4, 302, 10.2174/1874192401004010302
Gimbrone, 2016, Endothelial cell dysfunction and the pathobiology of atherosclerosis, Circ Res, 118, 620, 10.1161/CIRCRESAHA.115.306301
Moncada, 1997, Nitric oxide in the vasculature: physiology and pathophysiology, Ann N Y Acad Sci, 811, 60, 10.1111/j.1749-6632.1997.tb51989.x
Radomski, 1987, The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide, Br J Pharmacol, 92, 639, 10.1111/j.1476-5381.1987.tb11367.x
Moncada, 2006, Adventures in vascular biology: a tale of two mediators, Philos Trans R Soc Lond B Biol Sci, 361, 735, 10.1098/rstb.2005.1775
Darimont, 1994, In situ microdialysis of prostaglandins in adipose tissue: stimulation of prostacyclin release by angiotensin II, Int J Obes Relat Metab Disord, 18, 783
Cheng, 2002, Role of prostacyclin in the cardiovascular response to thromboxane A2, Science, 296, 539, 10.1126/science.1068711
Zellers, 1994, Interaction among ET-1, endothelium-derived nitric oxide, and prostacyclin in pulmonary arteries and veins, Am J Physiol, 267, H139, 10.1152/ajpheart.1994.267.1.H139
Tousoulis, 2012, The role of nitric oxide on endothelial function, Curr Vasc Pharmacol, 10, 4, 10.2174/157016112798829760
Noris, 1995, Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions, Circ Res, 76, 536, 10.1161/01.RES.76.4.536
Arnet, 1996, Regulation of endothelial nitric-oxide synthase during hypoxia, J Biol Chem, 271, 15069, 10.1074/jbc.271.25.15069
Godo, 2017, Divergent roles of endothelial nitric oxide synthases system in maintaining cardiovascular homeostasis, Free Radic Biol Med, 109, 4, 10.1016/j.freeradbiomed.2016.12.019
Salvemini, 2006, Superoxide, peroxynitrite and oxidative/nitrative stress in inflammation, Biochem Soc Trans, 34, 965, 10.1042/BST0340965
Stockklauser-Farber, 2000, Influence of diabetes on cardiac nitric oxide synthase expression and activity, Biochim Biophys Acta, 1535, 10, 10.1016/S0925-4439(00)00078-8
Endemann, 2004, Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus, Curr Hypertens Rep, 6, 85, 10.1007/s11906-004-0081-x
Treweeke, 2017, Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysis, PLoS ONE, 12, e0178171, 10.1371/journal.pone.0178171
Zafar, 2018, Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis, Diabetol Metab Syndr, 10, 62, 10.1186/s13098-018-0363-0
Wright, 1989, Generation of nitric oxide by human neutrophils, Biochem Biophys Res Commun, 160, 813, 10.1016/0006-291X(89)92506-0
Lambden, 2019, Bench to bedside review: therapeutic modulation of nitric oxide in sepsis-an update, Intensive Care Med Exp, 7, 64, 10.1186/s40635-019-0274-x
Alvarez, 2020, Home Nitric Oxide Therapy for COVID-19, Am J Respir Crit Care Med, 202, 16, 10.1164/rccm.202005-1906ED
Apte, 2019, VEGF in signaling and disease: beyond discovery and development, Cell, 176, 1248, 10.1016/j.cell.2019.01.021
Schulte, 2011, Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability, EMBO J, 30, 4157, 10.1038/emboj.2011.304
Forsythe, 1996, Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1, Mol Cell Biol, 16, 4604, 10.1128/MCB.16.9.4604
Burtenshaw, 2019, Reactive Oxygen Species (ROS), intimal thickening, and subclinical atherosclerotic disease, Front Cardiovasc Med, 6, 89, 10.3389/fcvm.2019.00089
Fiorello, 2020, The impact of glucose exposure on bioenergetics and function in a cultured endothelial cell model and the implications for cardiovascular health in diabetes, Sci Rep, 10, 19547, 10.1038/s41598-020-76505-4
Polgar, 2005, The P-selectin, tissue factor, coagulation triad, J Thromb Haemost, 3, 1590, 10.1111/j.1538-7836.2005.01373.x
Blann, 2003, The adhesion molecule P-selectin and cardiovascular disease, Eur Heart J, 24, 2166, 10.1016/j.ehj.2003.08.021
Tessaro, 2015, Lipid mediators are critical in resolving inflammation: a review of the emerging roles of eicosanoids in diabetes mellitus, BioMed Research International, 2015, 568408, 10.1155/2015/568408
Luo, 2011, Eicosanoids, β-cell function, and diabetes, Prostagl Other Lipid Mediators, 95, 1, 10.1016/j.prostaglandins.2011.06.001
Yan, 2006, Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding protein, Int J Biochem Cell Biol, 38, 1417, 10.1016/j.biocel.2006.02.003
Chopra, 2019, IRE1alpha-XBP1 signaling in leukocytes controls prostaglandin biosynthesis and pain, Science, 365, eaau6499, 10.1126/science.aau6499
Dennis, 2015, Eicosanoid storm in infection and inflammation, Nat Rev Immunol, 15, 511, 10.1038/nri3859
Vane, 1998, Mechanism of action of nonsteroidal anti-inflammatory drugs, Am J Med, 104, 2S, 10.1016/S0002-9343(97)00203-9
Ogawa, 2008, Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial, JAMA, 300, 2134, 10.1001/jama.2008.623
Belch, 2008, The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease, BMJ, 337, a1840, 10.1136/bmj.a1840
Pignone, 2010, Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation, Diabetes care, 33, 1395, 10.2337/dc10-0555
Group, 2018, Effects of aspirin for primary prevention in persons with diabetes mellitus, N Engl J Med, 379, 1529, 10.1056/NEJMoa1804988
Xing, 2019, Aspirin for primary prevention of cardiovascular disease in diabetes, J Diabetes Investig, 10, 899, 10.1111/jdi.13006
FitzGerald, 2001, The coxibs, selective inhibitors of cyclooxygenase-2, N Engl J Med, 345, 433, 10.1056/NEJM200108093450607
Howard, 2004, Nonsteroidal anti-inflammatory drugs and cardiovascular risk, J Am College Cardiol, 43, 519, 10.1016/j.jacc.2003.09.043
Belton, 2000, Cyclooxygenase-1 and−2-dependent prostacyclin formation in patients with atherosclerosis, Circulation, 102, 840, 10.1161/01.CIR.102.8.840
Catella-Lawson, 2001, Cyclooxygenase inhibitors and the antiplatelet effects of aspirin, N Engl J Med, 345, 1809, 10.1056/NEJMoa003199
Reichman, 1986, Effects of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model, J Neurosurg, 65, 233, 10.3171/jns.1986.65.2.0233
Tarnawski, 2003, Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications, J Mol Med, 81, 627, 10.1007/s00109-003-0479-y
Williams, 1973, Prostaglandins as potentiators of increased vascular permeability in inflammation, Nature, 246, 215, 10.1038/246215a0
Pai, 2001, PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways, Biochem Biophys Res Commun, 286, 923, 10.1006/bbrc.2001.5494
Mazzeo, 1998, Decreased IL-12 production and Th1 cell development by acetyl salicylic acid-mediated inhibition of NF-kappaB, Eur J Immunol, 28, 3205, 10.1002/(SICI)1521-4141(199810)28:10<3205::AID-IMMU3205>3.0.CO;2-8
Inaoka, 2006, Non-steroidal anti-inflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells, Exp Dermatol, 15, 981, 10.1111/j.1600-0625.2006.00505.x
Cianferoni, 2001, Selective inhibition of interleukin-4 gene expression in human T cells by aspirin, Blood, 97, 1742, 10.1182/blood.V97.6.1742
Torjesen, 2020, Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases, BMJ, 369, m1409, 10.1136/bmj.m1409
Qiao, 2015, Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats, Cardiology, 131, 97, 10.1159/000375362
Mancia, 2020, Renin-angiotensin-aldosterone system blockers and the risk of Covid-19, N Engl J Med, 382, 2431, 10.1056/NEJMoa2006923
Chen, 2020, Cyclooxgenase-2 is induced by SARS-CoV-2 infection but does not affect viral entry or replication, bioRxiv, 10.1101/2020.09.24.312769
Torjesen, 2020, Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear, BMJ, 369, m1555, 10.1136/bmj.m1555
Pyrillou, 2018, Dexamethasone induces omega3-derived immunoresolvents driving resolution of allergic airway inflammation, J Allergy Clin Immunol, 142, 691, 10.1016/j.jaci.2018.04.004
Group, 2020, Dexamethasone in hospitalized patients with Covid-19 - preliminary report, N Engl J Med, 10.1056/NEJMoa2021436
Alessi, 2020, Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes, Diabetol Metab Syndr, 12, 80, 10.1186/s13098-020-00583-7
2020, COVID-19 coagulopathy: an evolving story, Lancet Haematol, 7, e425, 10.1016/S2352-3026(20)30151-4
Klok, 2020, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb Res, 191, 145, 10.1016/j.thromres.2020.04.013
Martin-Rojas, 2020, COVID-19 coagulopathy: An in-depth analysis of the coagulation system, Eur J Haematol, 105, 741, 10.1111/ejh.13501
Pretorius, 2018, Platelet activity and hypercoagulation in type 2 diabetes, Cardiovasc Diabetol, 17, 141, 10.1186/s12933-018-0783-z
Wang, 2018, Hyperglycemia induces neutrophil extracellular traps formation through an NADPH oxidase-dependent pathway in diabetic retinopathy, Front Immunol, 9, 3076, 10.3389/fimmu.2018.03076
Zucoloto, 2019, Platelet-neutrophil interplay: insights into Neutrophil Extracellular Trap (NET)-driven coagulation in infection, Front Cardiovasc Med, 6, 85, 10.3389/fcvm.2019.00085
Abou-Ismail, 2020, The hypercoagulable state in COVID-19: incidence, pathophysiology, and management, Thrombosis Res, 194, 101, 10.1016/j.thromres.2020.06.029
Tang, 2020, Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thrombosis Haemostasis, 18, 1094, 10.1111/jth.14817
Rahadian, 2020, Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice, Journal of Atherosclerosis and Thrombosis, 27, 1141, 10.5551/jat.52100
Testa, 2020, Direct oral anticoagulant plasma levels' striking increase in severe COVID-19 respiratory syndrome patients treated with antiviral agents: the Cremona experience, J Thromb Haemost, 18, 1320, 10.1111/jth.14871
Lonnrot, 2017, Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study, Diabetologia, 60, 1931, 10.1007/s00125-017-4365-5
Yang, 2010, Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes, Acta Diabetol, 47, 193, 10.1007/s00592-009-0109-4
Marchand, 2020, Type 1 diabetes onset triggered by COVID-19, Acta Diabetol, 57, 1265, 10.1007/s00592-020-01570-0
Yang, 2020, A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids, Cell Stem Cell, 27, 125, 10.1016/j.stem.2020.06.015
Carlsson, 1998, Angiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats, Diabetologia, 41, 127, 10.1007/s001250050880